课题基金 / 基金详情

CLINICAL TRIAL: LCCC 0418: PHASE I/II MULTIEPTITOPE DENDRITIC CELL VACCINE IN B

CLINICAL TRIAL: LCCC 0418: PHASE I/II MULTIEPTITOPE DENDRITIC CELL VACCINE IN B
临床试验：LCCC 0418：B 期 I/II 期多位树突状细胞疫苗
批准号：
7716825
负责人：
Jonathan S. Serody
金额：
$0.27万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-04-02 至 2008-05-31
来源：
https://reporter.nih.gov/project-details/7716825
关键词：
AntibodiesClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDendritic Cell VaccineDendritic CellsFundingGrantInstitutionPhasePurposeResearchResearch PersonnelResourcesSourceTestingUnited States National Institutes of Healthchemotherapykillingsneoplastic cell

项目摘要

项目成果

Jonathan S. Serody的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test whether giving dendritic cells with chemotherapy and an antibody, which are effective in killing tumor cells, will be more effective than what has been previously found with giving the chemotherapy and antibody without using dendritic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UNC Immunotherapy Training Grant (IM-TAG)
SToP Cancer SPORE: Career Enhancement Program
SToP Cancer SPORE: Career Enhancement Program
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
海外基金